Patents by Inventor Ryozo Oishi

Ryozo Oishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
    Patent number: 8613962
    Abstract: There is provided a medicinal agent that is effective and highly safe for the prevention or alleviation of a peripheral nerve disorder that develops as a side effect occurring after the administration of an anti-cancer agent. The present invention relates to a novel medical use of an extract from inflamed tissues inoculated with vaccinia virus, and to a prophylactic or alleviating agent for a peripheral nerve disorder that contains the extract as an active ingredient. The agent containing the extract as an active ingredient is used for a prophylactic or alleviating agent for a peripheral nerve disorder induced by an anti-cancer agent and is a highly safe and remarkably highly useful medicinal agent with few side effects.
    Type: Grant
    Filed: August 28, 2008
    Date of Patent: December 24, 2013
    Assignees: Kyushu University, National University Corporation, Nippon Zoki Pharmaceutical Co., Ltd
    Inventors: Ryozo Oishi, Yoshinori Itoh, Nobuaki Egashira
  • PROPHYLACTIC OR ALLEVIATING AGENT FOR PERIPHERAL NERVE DISORDER INDUCED BY ANTI-CANCER AGENT
    Publication number: 20110111051
    Abstract: There is provided a medicinal agent that is effective and highly safe for the prevention or alleviation of a peripheral nerve disorder that develops as a side effect occurring after the administration of an anti-cancer agent. The present invention relates to a novel medical use of an extract from inflamed tissues inoculated with vaccinia virus, and to a prophylactic or alleviating agent for a peripheral nerve disorder that contains the extract as an active ingredient. The agent containing the extract as an active ingredient is used for a prophylactic or alleviating agent for a peripheral nerve disorder induced by an anti-cancer agent and is a highly safe and remarkably highly useful medicinal agent with few side effects.
    Type: Application
    Filed: August 28, 2008
    Publication date: May 12, 2011
    Applicants: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, NIPPON ZOKI PHARMACEUTICAL CO., LTD.
    Inventors: Ryozo Oishi, Yoshinori Itoh, Nobuaki Egashira